|
Santa Monica, CA – May 31, 2005 – Bison
Capital Structured Equity Partners, LLC announced its $11
million investment in Metagenics, Inc., the leading provider
of medical foods and nutraceuticals to licensed healthcare
professionals worldwide. Founded in 1983 and based in San
Clemente, California, Metagenics’ goal is to help people
achieve their genetic potential through nutrition. Metagenics
currently sells over 400 all-natural, research-based products
formulated to treat the chronic health problems associated
with cardiovascular disease, inflammation, gastrointestinal
disease and endocrine-related disorders.
With over 500 employees worldwide, including
a team of over 30 scientists and clinicians, Metagenics is
helping to shape the future of the nutraceutical industry
and integrative medicine. Metagenics has built a reputation
for providing products that meet the highest standards of
safety, efficacy, and quality. The company complies with
the rigorous standards for Good Manufacturing Practices and
is certified by the National Nutritional Foods Association
(“NNFA”), NSF International (“NSF”),
and the Therapeutic Goods Administration of Australia (“TGA”).
“We are very excited to be forming a
partnership with Metagenics. We believe that the company’s
superior management team and pioneering research and development
efforts will allow Metagenics to retain its leading position
in this high growth segment of the dietary supplement market.
Our capital, which enables the company to consummate two
acquisitions, will help Metagenics continue its impressive
growth trajectory,” said Ping Chu, a partner at Bison
Capital.
Bison Capital partners exclusively with management
teams, providing growth capital to public and private entrepreneurial
companies. The firm’s capital typically funds expansion
opportunities, acquisitions and balance sheet restructurings. |
